Boehringer to manufacture Servier’s gevokizumab
Will produce inflammatory disease drug at its Biberach facility
Read MoreSection: Research
BMS halts trial of hepatitis C drug on safety issues
At least one person in study thought to have developed congestive heart failure
Read More
Pfizer sells Kent R&D centre to property consortium
Discovery Park Ltd takes over site 18 months after US pharma firm announced plans to exit it
Read More
GSK’s Olympic doping facility to research personalised medicines after Games
MRC-NIHR Phenome Centre is “phenomenal legacy” from London 2012 says MRC’s Prof John Savill
Read More
Interview: Charles Mgone, EDCTP
The executive director of the European and Developing Countries Clinical Trials Partnership talks to Linda Banks about partnerships and clinical trial success stories
Read More